Skip Navigation



Brain Advance Access published online on December 22, 2003

Brain, doi:10.1093/brain/awh067
© 2003 by Guarantors of Brain
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/3/550    most recent
awh067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Foltynie, T.
Right arrow Articles by Barker, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foltynie, T.
Right arrow Articles by Barker, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The Guarantors of Brain

Article

The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study

Thomas Foltynie 1*, Carol E. G. Brayne 2, Trevor W. Robbins 3, and Roger A. Barker 1

1 Cambridge Centre for Brain Repair, Cambridge CB2 2PY, UK
2 Department of Public Health and Primary Care, Institute of Public Health, Cambridge CB2 2PY, UK
3 Department of Experimental Psychology, University of Cambridge, Downing Street, Cambridge, CB2 2PY, UK

* Corresponding author. E-mail: tf210{at}medschl.cam.ac.uk.

Received 1 August 2003 ; revised 21 August 2003 ; accepted 23 October 2003

Abstract

We have used multiple sources to identify a population-representative cohort of newly diagnosed patients with parkinsonism and Parkinson’s disease in the UK over a 2-year period. All patients have been invited to participate in a detailed clinical assessment either at home or in an outpatient clinic. These assessments have been used to refine clinical diagnoses of parkinsonism using established criteria, and describe some of the phenotypic variability of Parkinson’s disease at the time of diagnosis. The crude incidence of Parkinson’s disease was 13.6/105yr-1 [confidence interval (CI) 11.8-15.6 and of parkinsonism was 20.9/105yr-1 (CI 18.7-23.3). Age-standardized to the 1991 European population, the incidence figures become 10.8/105yr-1 (CI 9.4-12.4) for Parkinson’s disease and 16.6/105yr-1 (CI 14.8-18.6) for parkinsonism. Thirty-six per cent of the Parkinson’s disease patients had evidence of cognitive impairment based on their performance in the Mini-Mental State Examination, a pattern recognition task, and the Tower of London task. The pattern of cognitive deficits seen among these patients using these and further cognitive tasks suggests that sub-groups of patients based on cognitive ability might be identifiable even in the early stages of disease, which may reflect regional differences in the underlying neuropathological processes.

Keywords: incidence; Parkinson’s disease; parkinsonism; cognitive
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
L. A. B. Wisman, G. Sahin, M. Maingay, G. Leanza, and D. Kirik
Functional Convergence of Dopaminergic and Cholinergic Input Is Critical for Hippocampus-Dependent Working Memory
J. Neurosci., July 30, 2008; 28(31): 7797 - 7807.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Huang, P. Mattis, K. Perrine, N. Brown, V. Dhawan, and D. Eidelberg
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease
Neurology, April 15, 2008; 70(16_Part_2): 1470 - 1477.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. H. Williams-Gray, A. Hampshire, R. A. Barker, and A. M. Owen
Attentional control in Parkinson's disease is dependent on COMT val158met genotype
Brain, February 1, 2008; 131(2): 397 - 408.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Vendette, J. -F. Gagnon, A. Decary, J. Massicotte-Marquez, R. B. Postuma, J. Doyon, M. Panisset, and J. Montplaisir
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia
Neurology, November 6, 2007; 69(19): 1843 - 1849.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Verbaan, J Marinus, M Visser, S M van Rooden, A M Stiggelbout, H A M Middelkoop, and J J van Hilten
Cognitive impairment in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1182 - 1187.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K. Bronnick, M. Emre, R. Lane, S. Tekin, and D. Aarsland
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1064 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K S M Taylor, J A Cook, and C E Counsell
Heterogeneity in male to female risk for Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 905 - 906.
[Full Text] [PDF]


Home page
BrainHome page
C. H. Williams-Gray, T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Brain, July 1, 2007; 130(7): 1787 - 1798.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. H. Williams-Gray, A. Hampshire, T. W. Robbins, A. M. Owen, and R. A. Barker
Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease
J. Neurosci., May 2, 2007; 27(18): 4832 - 4838.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. K Beyer, C. C Janvin, J. P Larsen, and D. Aarsland
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 254 - 259.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Aarsland, K Bronnick, U Ehrt, P P De Deyn, S Tekin, M Emre, and J L Cummings
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Bronnick, U Ehrt, M Emre, P P De Deyn, K Wesnes, S Tekin, and D Aarsland
Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1136 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C H Williams-Gray, A Goris, T Foltynie, J Brown, M Maranian, A Walton, D A S Compston, S J Sawcer, and R A Barker
Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort
J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 665 - 667.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Muslimovic, B. Post, J. D. Speelman, and B. Schmand
Cognitive profile of patients with newly diagnosed Parkinson disease
Neurology, October 25, 2005; 65(8): 1239 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
C. C. Janvin, D. Aarsland, and J. P. Larsen
Cognitive Predictors of Dementia in Parkinson's Disease: A Community-Based, 4-Year Longitudinal Study
J Geriatr Psychiatry Neurol, September 1, 2005; 18(3): 149 - 154.
[Abstract] [PDF]


Home page
NeurologyHome page
C. W.C. Tam, E. J. Burton, I. G. McKeith, D. J. Burn, and J. T. O'Brien
Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies
Neurology, March 8, 2005; 64(5): 861 - 865.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Z. Press
Parkinson's Disease Dementia -- A First Step?
N. Engl. J. Med., December 9, 2004; 351(24): 2547 - 2549.
[Full Text] [PDF]


Home page
BrainHome page
A. W. Michell, S. J. G. Lewis, T. Foltynie, and R. A. Barker
Biomarkers and Parkinson's disease
Brain, August 1, 2004; 127(8): 1693 - 1705.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.